BCR and Burkitt lymphoma: Importantly, using NFAT activation of a reporter plasmid as a readout of NFAT activity, we showed that EBNA2 repressed BCR-mediated NFAT activation in Burkitt lymphoma cells and EBNA3-mediated suppression of mostly basal NFAT activity.